TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
NRXS

Neuraxis, Inc.

Healthcare · Biotechnology

7.60$ -2.5% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement NRXS
Line item 2020 2021 2022 2023 2024 2025
– +41.0% -1.3% -8.4% +9.2% +32.9%
– -2.8% -36.5% +2.1% +19.3% +55.5%
– +55.5% +5.9% -9.7% +7.8% +29.4%
– +22.0% +10.9% -25.0% +21.7% +139.5%
– -6.5% +12.2% +62.6% +7.5% -9.9%
– -6.2% +10.3% +53.1% +7.5% +14.3%
– – – – – –
– -51.2% +1,030.9% +1,183.1% -94.4% -75.4%
– – – – – –
– -86.1% +850.3% +1,148.5% -253.7% –
– – – – – –
– – – – – –

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?